ArticleJournal of animal science and biotechnology2026
Rumen unprotected glucose tends to promote intramuscular fat deposition via microbial volatile fatty acid-mediated metabolic reprogramming in cattle: a multi-omics perspective through the rumen-jejunum axis.
Article in Journal of animal science and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe regulatory effects of glucose absorption at different sites (rumen vs. small intestine) on lipid metabolism exhibit significant variation in beef nutrition. This study aimed to investigate the regulatory pathways of rumen-protected or unprotected glucose on lipid metabolism through the rumen-jejunum axis in Xinjiang Brown cattle.
resultsThirty Xinjiang Brown cattle (females) with similar initial weight (410 ± 22.4 kg) were randomly assigned to 3 treatment groups (n = 10 animals per group). The experimental groups were fed a basal diet with the following daily supplements per head: 150 g palmitate coating (CON group), 150 g palmitate coating plus 150 g rumen-unprotected glucose (RUG group), and 300 g rumen-protected glucose (containing 50% glucose; RPG group). The experiment lasted for 70 d. Supplementation with both rumen-unprotected glucose and rumen-protected glucose increased chest width (P = 0.001), chest girth (P = 0.013), abdominal girth (P = 0.002), backfat thickness (P = 0.041), omental fat weight (P = 0.047), as well as serum concentrations of insulin (P < 0.001), glucagon-like peptide-1 (P < 0.001), and 5-hydroxytryptamine (P < 0.001), while decreasing the content of deoxycholic acid (P < 0.001) in the jejunum. The inclusion of rumen-unprotected glucose resulted in a trend toward higher intramuscular fat (IMF) (P = 0.064) in the longissimus thoracis, along with significant increases in C14:0 (P = 0.042), C15:0 (P = 0.014), and marbling score (P = 0.048), as well as significant reductions in drip loss (P = 0.022) and shear force (P = 0.041). These changes were accompanied by significant increases in dry matter intake (P = 0.001), ruminal concentrations of acetate (P = 0.022) and propionate (P = 0.011). The rumen-protected glucose supplementation elevated serum glucose (P < 0.001) level, while enhancing digestibility of ether extract (P = 0.027) and neutral detergent fiber (P = 0.027). Neither rumen-unprotected glucose nor rumen-protected glucose affected the alpha diversity and beta diversity of ruminal and jejunal microbiota (P > 0.05), but the differential bacterial biomarkers were either positively or negatively correlated with chest girth, abdominal girth, marbling score, backfat thickness, and deoxycholic acid (P < 0.05).
conclusionRumen-unprotected glucose supplementation enhances IMF deposition and meat quality attributes through microbial volatile fatty acid-driven metabolic reprogramming.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.